Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Spire Healthcare ( (GB:SPI) ) just unveiled an update.
Spire Healthcare Group plc has declared a final dividend of 1.5 pence per ordinary share, payable in sterling to shareholders on 19 June 2026. The dividend will be paid on ordinary shares of 1 pence each, with an ex-dividend date of 21 May 2026 and a record date of 22 May 2026.
The announcement underlines Spire Healthcare’s intention to return cash to shareholders, signalling confidence in its financial position and cash generation. The lack of alternative dividend options, such as scrip or DRIP, means investors will receive the payout solely in cash, providing straightforward income for existing shareholders.
The most recent analyst rating on (GB:SPI) stock is a Buy with a £2.75 price target. To see the full list of analyst forecasts on Spire Healthcare stock, see the GB:SPI Stock Forecast page.
Spark’s Take on SPI Stock
According to Spark, TipRanks’ AI Analyst, SPI is a Neutral.
The score is primarily supported by solid operating performance and consistent cash generation, but it is weighed down by high leverage and weak bottom-line profitability. Technical indicators are notably weak with the price below key moving averages and negative MACD, and valuation also detracts due to a high P/E with only a modest dividend yield.
To see Spark’s full report on SPI stock, click here.
More about Spire Healthcare
Spire Healthcare Group plc is a U.K.-based private healthcare provider operating a network of hospitals and clinics. The company focuses on delivering elective surgery, diagnostic services, and specialist medical care to insured, self-pay, and NHS-funded patients across its regional footprint.
Average Trading Volume: 1,574,770
Technical Sentiment Signal: Sell
Current Market Cap: £613.2M
For detailed information about SPI stock, go to TipRanks’ Stock Analysis page.

